TY - JOUR
T1 - Human CRY1 variants associate with attention deficit/hyperactivity disorder
AU - Emre Onat, O.
AU - Ece Kars, M.
AU - Gül, Şeref
AU - Bilguvar, Kaya
AU - Wu, Yiming
AU - Özhan, Ayşe
AU - Aydın, Cihan
AU - Nazlı Başak, A.
AU - Allegra Trusso, M.
AU - Goracci, Arianna
AU - Fallerini, Chiara
AU - Renieri, Alessandra
AU - Casanova, Jean Laurent
AU - Itan, Yuval
AU - Atbaşoğlu, Cem E.
AU - Saka, Meram C.
AU - Halil Kavaklı, Kavaklı
AU - Özçelik, Tayfun
N1 - Publisher Copyright:
Copyright: © 2020, American Society for Clinical Investigation.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Attention deficit/hyperactivity disorder (ADHD) is a common and heritable phenotype frequently accompanied by insomnia, anxiety, and depression. Here, using a reverse phenotyping approach, we report heterozygous coding variations in the core circadian clock gene cryptochrome 1 in 15 unrelated multigenerational families with combined ADHD and insomnia. The variants led to functional alterations in the circadian molecular rhythms, providing a mechanistic link to the behavioral symptoms. One variant, CRY1Δ11 c.1657+3A>C, is present in approximately 1% of Europeans, therefore standing out as a diagnostic and therapeutic marker. We showed by exome sequencing in an independent cohort of patients with combined ADHD and insomnia that 8 of 62 patients and 0 of 369 controls carried CRY1Δ11. Also, we identified a variant, CRY1Δ6 c.825+1G>A, that shows reduced affinity for BMAL1/CLOCK and causes an arrhythmic phenotype. Genotype-phenotype correlation analysis revealed that this variant segregated with ADHD and delayed sleep phase disorder (DSPD) in the affected family. Finally, we found in a phenome-wide association study involving 9438 unrelated adult Europeans that CRY1Δ11 was associated with major depressive disorder, insomnia, and anxiety. These results defined a distinctive group of circadian psychiatric phenotypes that we propose to designate as “circiatric” disorders.
AB - Attention deficit/hyperactivity disorder (ADHD) is a common and heritable phenotype frequently accompanied by insomnia, anxiety, and depression. Here, using a reverse phenotyping approach, we report heterozygous coding variations in the core circadian clock gene cryptochrome 1 in 15 unrelated multigenerational families with combined ADHD and insomnia. The variants led to functional alterations in the circadian molecular rhythms, providing a mechanistic link to the behavioral symptoms. One variant, CRY1Δ11 c.1657+3A>C, is present in approximately 1% of Europeans, therefore standing out as a diagnostic and therapeutic marker. We showed by exome sequencing in an independent cohort of patients with combined ADHD and insomnia that 8 of 62 patients and 0 of 369 controls carried CRY1Δ11. Also, we identified a variant, CRY1Δ6 c.825+1G>A, that shows reduced affinity for BMAL1/CLOCK and causes an arrhythmic phenotype. Genotype-phenotype correlation analysis revealed that this variant segregated with ADHD and delayed sleep phase disorder (DSPD) in the affected family. Finally, we found in a phenome-wide association study involving 9438 unrelated adult Europeans that CRY1Δ11 was associated with major depressive disorder, insomnia, and anxiety. These results defined a distinctive group of circadian psychiatric phenotypes that we propose to designate as “circiatric” disorders.
UR - https://www.scopus.com/pages/publications/85087533324
U2 - 10.1172/JCI135500
DO - 10.1172/JCI135500
M3 - Article
C2 - 32538895
AN - SCOPUS:85087533324
SN - 0021-9738
VL - 130
SP - 3885
EP - 3900
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 7
ER -